1. Negative trial results are important to understand the mechanisms of multimodality therapy in gastric cancer

   • Christoph Schuhmacher

   Editorial 01 July 2011 Pages: 203 - 205

2. Second-line chemotherapy for gastric cancer: a new issue lies ahead in global trials

   • Hiroya Takiuchi

   Review article 23 July 2011 Pages: 206 - 211

3. Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2

   • Isao Miyashiro
   • Hiroshi Furukawa
   • The Gastric Cancer Surgical Study Group in the Japan Clinical Oncology Group

   Original Article 19 February 2011 Pages: 212 - 218

   

4. Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum

   • Katrine R. Schoennemann
   • Jon K. Bjerregaard
   • Per Pfeiffer

   Original Article 17 March 2011 Pages: 219 - 225

   

5. A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

   • Tetsuya Hamaguchi
   • Kuniaki Shirao
   • Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group

   Original Article 19 April 2011 Pages: 226 - 233

   

6. Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany

   • Radoslaw Jaworski
   • Elfriede Bollschweiler
   • Janusz Jaskiewicz

   Original Article Open access 26 March 2011 Pages: 234 - 241

   

7. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population

   • Hye-Rim Song
   • Sun-Seog Kweon
   • Min-Ho Shin

   Original Article 02 April 2011 Pages: 242 - 247

8. Erratum to: p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population

   • Hye-Rim Song
   • Sun-Seog Kweon
   • Min-Ho Shin

   Erratum 22 July 2011 Pages: 248 - 248

9. Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer

   • Hyun Jeong Shim
   • Ju Young Yun
   • Ik Joo Chung

   Original Article 23 March 2011 Pages: 249 - 256

   

10. Increased risk of tuberculosis after gastrectomy and chemotherapy in gastric cancer: a 7-year cohort study

    • Shiang-Fen Huang
    • Chung-Pin Li
    • Wei-Juin Su

    Original Article 19 April 2011 Pages: 257 - 265

    

11. IL-6 serum levels predict postoperative morbidity in gastric cancer patients

    • Antoni M. Szczepanik
    • Lucyna Scislo
    • Jan Kulig

    Original Article Open access 20 April 2011 Pages: 266 - 273

    

12. Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1

    • Toru Aoyama
    • Takaki Yoshikawa
    • Akira Tsuburaya

    Original Article 02 April 2011 Pages: 274 - 278

    

13. Functional outcomes according to the size of the gastric remnant and type of reconstruction following laparoscopic distal gastrectomy for gastric cancer

    • Eiji Nomura
    • Sang-Woong Lee
    • Nobuhiko Tanigawa

    Original Article 26 April 2011 Pages: 279 - 284

    

14. Does immigration play a role in the risk of gastric cancer by site and by histological type? A study of first-generation immigrants in Sweden

    • Seyed Mohsen Mousavi
    • Jan Sundquist
    • Kari Hemminki

    Short Communication 23 March 2011 Pages: 285 - 289

15. Gastric adenocarcinoma with rhabdoid morphology

    • Kohei Shomori
    • Kenji Sugamura
    • Hisao Ito

    Case Report 17 March 2011 Pages: 290 - 294

    

16. Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy

    • Masaaki Saito
    • Hirokazu Kiyozaki
    • Fumio Konishi

    Case report 14 June 2011 Pages: 295 - 299